Slamon Dennis has filed 4 insider transactions across 1 company since May 2023.
Most recent transaction: a option exercise of 10000 shares of BIOMARIN PHARMACEUTICAL INC ($BMRN) on March 18, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 18, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Slamon Dennis | Director | M | Common Stock | 10000 | $79.70 | 40,809.0000 | 191,595,000 | 32.46% | 0.01% |
| March 18, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Slamon Dennis | Director | F | Common Stock | 9510 | $83.81 | 31,299.0000 | 191,595,000 | 23.30% | 0.00% |
| March 18, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Slamon Dennis | Director | M | Stock Option (Right to Buy Common Stock) | 10000 | $0.00 | 0.0000 | 191,595,000 | 100.00% | 0.01% |
| May 23, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Slamon Dennis | Director | A | Common Stock | 4190 | $0.00 | 30,809.0000 | 188,963,000 | 15.74% | 0.00% |